Literature DB >> 14711063

Obesity and type 2 diabetes.

Carol A Maggio1, F Xavier Pi-Sunyer.   

Abstract

The increasing prevalence of obesity is accompanied by an increasing prevalence of type 2 diabetes. Obesity not only increases the risk of developing type 2 diabetes but also compounds its health risks and complicates its management. The health benefits of weight loss and the efficacy of current weight loss strategies in obese persons with type 2 diabetes are evaluated. In addition, the article reviews the results of lifestyle intervention trials designed to reduce conversion to type 2 diabetes in at-risk individuals.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14711063     DOI： 10.1016/s0889-8529(03)00071-9

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  59 in total

Review 1.  Caloric restriction and heart function: is there a sensible link?

Authors:  Xuefeng Han; Jun Ren
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

Review 2.  Drugs on the horizon for diabesity.

Authors:  Clifford J Bailey
Journal:  Curr Diab Rep       Date:  2005-10       Impact factor: 4.810

Review 3.  New therapies for diabesity.

Authors:  Clifford J Bailey
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

4.  Novel interactive cell-phone technology for health enhancement.

Authors:  David L Katz; Bjorn Nordwall
Journal:  J Diabetes Sci Technol       Date:  2008-01

Review 5.  Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism.

Authors:  Barbara Strasser; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sports Med       Date:  2010-05-01       Impact factor: 11.136

Review 6.  Social stigma in diabetes : a framework to understand a growing problem for an increasing epidemic.

Authors:  Jasmin Schabert; Jessica L Browne; Kylie Mosely; Jane Speight
Journal:  Patient       Date:  2013       Impact factor: 3.883

7.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

8.  Evidence for resistance training as a treatment therapy in obesity.

Authors:  Barbara Strasser; Wolfgang Schobersberger
Journal:  J Obes       Date:  2010-08-10

9.  Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.

Authors:  Min He; Haoran Su; Weiwei Gao; Stina M Johansson; Qing Liu; Xiaoyan Wu; Jiayu Liao; Andrew A Young; Tamas Bartfai; Ming-Wei Wang
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes.

Authors:  Loretta L Nielsen; Ted Okerson; John Holcombe; Byron Hoogwerf
Journal:  J Diabetes Sci Technol       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.